Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
Saved in:
| Title: | Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial. |
|---|---|
| Authors: | Parker CC; The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom., James ND; The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom., Brawley CD; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Clarke NW; The Christie Hospital, Manchester, United Kingdom.; Salford Royal Hospitals, Manchester, United Kingdom., Ali A; The Christie Hospital, Manchester, United Kingdom., Amos CL; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Attard G; UCL Cancer Institute, UCL, London, United Kingdom., Chowdhury S; Guys and St Thomas's NHS Foundation Trust, London, United Kingdom., Cook A; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Cross W; St James's University Hospital, Leeds, United Kingdom., Dearnaley DP; The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom., Douis H; University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Gilbert DC; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Gilson C; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Gillessen S; Istituto Oncologico della Svizzera Italiana, EOC, Bellinzona, Switzerland.; Università della Svizzera Italiana, Lugano, Switzerland., Hoyle A; The Christie Hospital, Manchester, United Kingdom.; Salford Royal Hospitals, Manchester, United Kingdom., Jones RJ; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Langley RE; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Malik ZI; Clatterbridge Cancer Centre, Liverpool, United Kingdom., Mason MD; Cardiff University, Cardiff, United Kingdom., Matheson D; University of Wolverhampton, Wolverhampton, United Kingdom., Millman R; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Rauchenberger M; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Rush H; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom.; Guys and St Thomas's NHS Foundation Trust, London, United Kingdom., Russell JM; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Sweeney H; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Bahl A; University Hospitals Bristol NHS Trust, Bristol, United Kingdom., Birtle A; Rosemere Cancer Centre, Lancs Teaching Hospitals, University of Manchester, Manchester, United Kingdom.; UCLan, Lanchashire, United Kingdom., Capaldi L; Worcestershire Acute Hospitals NHS Trust, Worcester, United Kingdom., Din O; Weston Park Cancer Centre, Sheffield, United Kingdom., Ford D; University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Gale J; Queen Alexandra Hospital, Portsmouth, United Kingdom., Henry A; University of Leeds, Leeds, United Kingdom., Hoskin P; The Christie Hospital, Manchester, United Kingdom.; Mount Vernon Cancer Centre, Northwood, United Kingdom., Kagzi M; The James Cook University Hospital, Middlesbrough, United Kingdom., Lydon A; Torbay and South Devon NHS Trust, Torbay, United Kingdom., O'Sullivan JM; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, United Kingdom., Paisey SA; Hampshire Hospitals NHS Foundation Trust, Hampshire, United Kingdom., Parikh O; Royal Preston Hospital, Preston, United Kingdom., Pudney D; South West Wales Cancer Centre, Swansea, United Kingdom., Ramani V; The Christie Hospital, Manchester, United Kingdom.; Manchester University Hospitals NHS Trust, Manchester, United Kingdom., Robson P; Clatterbridge Cancer Centre, Liverpool, United Kingdom., Srihari NN; Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, United Kingdom., Tanguay J; Velindre Cancer Centre, Cardiff, United Kingdom., Parmar MKB; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Sydes MR; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom. |
| Corporate Authors: | STAMPEDE Trial Collaborative Group |
| Source: | PLoS medicine [PLoS Med] 2022 Jun 07; Vol. 19 (6), pp. e1003998. Date of Electronic Publication: 2022 Jun 07 (Print Publication: 2022). |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-1676 |
|---|---|
| DOI: | 10.1371/journal.pmed.1003998 |
